Literature DB >> 24946903

A single element in the 3'UTR of the apical sodium-dependent bile acid transporter controls both stabilization and destabilization of mRNA.

Dellys M Soler1, Ayantika Ghosh1, Frank Chen1, Benjamin L Shneider1.   

Abstract

mRNA stability appears to play a key role in the ontogenic regulation of the apical sodium-dependent bile acid transporter (ASBT). The RNA-binding proteins Hu antigen R (HuR) and tristetraprolin (TTP) stabilize and destabilize ASBT mRNA, respectively. Potential HuR-binding sites were assessed by sequence analysis in the context of prior in vitro functional analyses of the rat ASBT 3'UTR. Wild-type and mutant-binding sites were investigated by gel-shift analysis using IEC-6 cell extracts. The functional consequences of binding site mutations were assessed using two different hybrid reporter constructs linking the 3'UTR element to either a luciferase or a β-globin coding mRNA sequence. A specific metastasis-associated gene 1 (MTA1) cis-element was identified in the ASBT 3'UTR that became associated with proteins in IEC-6 cell extracts and could be supershifted by anti-HuR or anti-TTP antibodies. Mutation of this cis-element abrogated the gel shift of IEC-6 proteins. Furthermore, hybrid constructs containing a mutant MTA1 element had reduced responses to modulation of HuR or TTP. For the first time, we have identified a single specific sequence element in the 3'UTR of the rat ASBT mRNA that mediates counter-regulatory changes in mRNA abundance in response to both HuR and TTP.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24946903      PMCID: PMC5338459          DOI: 10.1042/BJ20140070

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  36 in total

1.  Messenger RNA half-life measurements in mammalian cells.

Authors:  Chyi-Ying A Chen; Nader Ezzeddine; Ann-Bin Shyu
Journal:  Methods Enzymol       Date:  2008       Impact factor: 1.600

2.  Diminished gene expression of ileal apical sodium bile acid transporter explains impaired absorption of bile acid in patients with hypertriglyceridemia.

Authors:  W C Duane; L A Hartich; A E Bartman; S B Ho
Journal:  J Lipid Res       Date:  2000-09       Impact factor: 5.922

3.  Parallel and independent regulation of interleukin-3 mRNA turnover by phosphatidylinositol 3-kinase and p38 mitogen-activated protein kinase.

Authors:  X F Ming; G Stoecklin; M Lu; R Looser; C Moroni
Journal:  Mol Cell Biol       Date:  2001-09       Impact factor: 4.272

4.  Transactivation of rat apical sodium-dependent bile acid transporter and increased bile acid transport by 1alpha,25-dihydroxyvitamin D3 via the vitamin D receptor.

Authors:  Xianghai Chen; Frank Chen; Shanjun Liu; Hartmut Glaeser; Paul A Dawson; Alan F Hofmann; Richard B Kim; Benjamin L Shneider; K Sandy Pang
Journal:  Mol Pharmacol       Date:  2006-02-15       Impact factor: 4.436

5.  Cholesterol dependent downregulation of mouse and human apical sodium dependent bile acid transporter (ASBT) gene expression: molecular mechanism and physiological consequences.

Authors:  C Thomas; J-F Landrier; D Gaillard; J Grober; M-C Monnot; A Athias; P Besnard
Journal:  Gut       Date:  2006-02-16       Impact factor: 23.059

6.  The mRNA binding proteins HuR and tristetraprolin regulate cyclooxygenase 2 expression during colon carcinogenesis.

Authors:  Lisa E Young; Sandhya Sanduja; Kristi Bemis-Standoli; Edsel A Pena; Robert L Price; Dan A Dixon
Journal:  Gastroenterology       Date:  2009-01-15       Impact factor: 22.682

7.  Diminished expression of apical sodium-dependent bile acid transporter in gallstone disease is independent of ileal inflammation.

Authors:  Arthur Holzer; Simone Harsch; Olga Renner; André Strohmeyer; Silke Schimmel; Jan Wehkamp; Peter Fritz; Eduard F Stange
Journal:  Digestion       Date:  2008-10-02       Impact factor: 3.216

Review 8.  The role of tristetraprolin in cancer and inflammation.

Authors:  Sandhya Sanduja; Fernando F Blanco; Lisa E Young; Vimala Kaza; Dan A Dixon
Journal:  Front Biosci (Landmark Ed)       Date:  2012-01-01

9.  The p38/MK2-driven exchange between tristetraprolin and HuR regulates AU-rich element-dependent translation.

Authors:  Christopher Tiedje; Natalia Ronkina; Mohammad Tehrani; Sonam Dhamija; Kathrin Laass; Helmut Holtmann; Alexey Kotlyarov; Matthias Gaestel
Journal:  PLoS Genet       Date:  2012-09-27       Impact factor: 5.917

10.  Competitive binding of CUGBP1 and HuR to occludin mRNA controls its translation and modulates epithelial barrier function.

Authors:  Ting-Xi Yu; Jaladanki N Rao; Tongtong Zou; Lan Liu; Lan Xiao; Miao Ouyang; Shan Cao; Myriam Gorospe; Jian-Ying Wang
Journal:  Mol Biol Cell       Date:  2012-11-14       Impact factor: 4.138

View more
  5 in total

Review 1.  Intestinal Absorption of Bile Acids in Health and Disease.

Authors:  Alexander L Ticho; Pooja Malhotra; Pradeep K Dudeja; Ravinder K Gill; Waddah A Alrefai
Journal:  Compr Physiol       Date:  2019-12-18       Impact factor: 9.090

2.  RNA-binding protein HuR enhances mineralocorticoid signaling in renal KC3AC1 cells under hypotonicity.

Authors:  Ingrid Lema; Larbi Amazit; Khadija Lamribet; Jérôme Fagart; Anne Blanchard; Marc Lombès; Nadia Cherradi; Say Viengchareun
Journal:  Cell Mol Life Sci       Date:  2017-07-25       Impact factor: 9.261

Review 3.  Post-transcriptional regulation of cytokine and growth factor signaling in cancer.

Authors:  Irina Vlasova-St Louis; Paul R Bohjanen
Journal:  Cytokine Growth Factor Rev       Date:  2016-12-02       Impact factor: 7.638

Review 4.  The control of inflammation via the phosphorylation and dephosphorylation of tristetraprolin: a tale of two phosphatases.

Authors:  Andrew R Clark; Jonathan L E Dean
Journal:  Biochem Soc Trans       Date:  2016-10-15       Impact factor: 5.407

5.  Organic Solute Transporter α-β Protects Ileal Enterocytes From Bile Acid-Induced Injury.

Authors:  Courtney B Ferrebee; Jianing Li; Jamie Haywood; Kimberly Pachura; Brian S Robinson; Benjamin H Hinrichs; Rheinallt M Jones; Anuradha Rao; Paul A Dawson
Journal:  Cell Mol Gastroenterol Hepatol       Date:  2018-01-12
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.